Detail of > 55-03-8
- MSDS Download

- CAS Number:
- 55-03-8
- Name:
L-Tyrosine,O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt (1:1)
- Superlist Name:
- Levothyroxine sodium
- Formula:
- C15H10I4NNaO4
- Molecular Structure:

- Synonyms:
- L-Tyrosine,O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt (9CI);Thyroxine,monosodium salt, L- (8CI);Berlthyrox;Dathroid;Droxine;Eferox;Elthyrone;Elthyroxine;Eltroxin;Euthyrox;Eutirox;L-Thyroxin Henning;L-Thyroxinemonosodium salt;L-Thyroxine sodium;L-Thyroxine sodium salt;Laevoxin;Letrox;Letter;Levaxin;Leventa;Levo-T;Levoroxine;Levothroid;Levothyrox;Levothyroxine sodium;Levotirox;Levotiroxina;Levoxyl;Monosodium thyroxine;NSC 259940;Oroxine;Puran T 4;Sodium L-thyroxine;Sodium levothyroxine;Sodium thyroxin;Sodium thyroxinate;Sodium thyroxine;Synthroid;Synthroidsodium;Synthrox;T 4KP;T4 Montpellier 100;Thevier;Throxinique;Thyradin;Thyradin S;Thyrax Duotab;Thyrex;Thyro 4;Thyrosit;Thyroxevan;Thyroxinesodium;Thyroxine sodium salt;Tiroidine;
- Molecular Weight:
- 799.86
- EINECS:
- 200-221-4
- Melting Point:
- 207-210 (dec.)(lit.)
- Boiling Point:
- 576.3 °C at 760 mmHg
- Flash Point:
- 302.3 °C
- Solubility:
- cell culture medium: 0.1 mg/mL in water
- Safety:
- 22-24/25Details
- Deleted CAS:
- 50809-32-0, 67809-22-7
Related products
- 55-03-8L-Tyrosine,O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt (1:1)
- 6106-07-6L-Tyrosine,O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt, hydrate (1:1:5)
- 25416-65-3L-Tyrosine,O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt, hydrate (9CI)
- 51-48-9L-Tyrosine,O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-
- 93982-30-0Phenol,2,3,4-trichloro-, sodium salt (1:1)
- 28672-98-21-Propyne-1-sulfonicacid, sodium salt (1:1)
- 352535-06-95-Pyrimidinecarboxylicacid, sodium salt (1:1)
- 85712-08-9Phenol,4-chloro-2-cyclohexyl-, sodium salt (1:1)
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 593-08-82-Tridecanone
- 23978-55-41,4,10,13-Tetraoxa-7,16-diazacyclooctadecane
- 55-03-8L-Tyrosine,O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt (1:1)
- 82419-36-1Ofloxacin
- 12220-47-2C.I. Acid Red 315
- 5550-12-95'-Guanylic acid,sodium salt (1:2)
- 4482-25-11,3-Benzenediamine,4,4'-[(4-methyl-1,3-phenylene)bis(2,1-diazenediyl)]bis[6-methyl-
- 139-13-9Aminotriacetic acid
- 22874-79-92-Butenoic acid, octylester
- 480-65-92H-Pyran-5-carboxylicacid, 4,6-dimethyl-2-oxo-
- 10388-19-9Benzamide, 3-iodo-
- 40039-93-8BISPHENOL A DIGLYCIDYL ETHER, BROMINATED
- 41267-76-91H,5H,11H-[1]Benzopyrano[6,7,8-ij]quinolizin-11-one,2,3,6,7-tetrahydro-9-methyl-
- 1072-67-93-Isoxazolamine,5-methyl-
- 50-86-24-Acetamidosalicylic acid
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(18)
United States(1)
Canada(1)
- Business Type:
- Importer/Exporter(13)Lab/Research institutions(3)
- Certificates:
- ISO(1) Production License (0)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Regulation of resistance to various toxicants by PCN (pregnenolone-16
- Regulation of resistance to various toxicants by PCN (pregnenolone-16.alpha.-carbonitrile) and thyroxine. Tache, Y.; Tache, J.; Mecs, I.Chemicals with cas numbers 57-33-0 and 53-21-4 also play role.; Du Ruisseau, P.; Selye, H. (Inst. Med. Chir. Exp., Univ. Montreal, Montreal, Que., Can.). J. Med. (Westbury, N. Y.), 7(6), 471-9 (English) 1976. CODEN: JNMDBO. DOCUMENT TYPE: Journal CA Section: 2 (Hormone Pharmacology) Section cross-reference(s): 1 In rats, pregnenolone-16.alpha.-carbonitrile (I) [1434-54-4] (1 or 10 mg twice daily, orally) inhbited the toxicity of antazoline [91-75-8], carbamazepine [298-46-4], cocaine-HNCl [53-21-4], guanethidine [55-65-2], ibuprofen [15687-27-1], ketamine-HCl [1867-66-9], LSD [50-37-3], nembutal [57-33-0], and reserpine [50-55-5], whereas (except in the case of nembutal) thyroxine Na salt (I Na salt) [55-03-8] sensitized the animals to intoxication with these same compds. Even much lower doses of I or II exerted similar but weaker effects. I-induced resistance to the various substrates was generally not altered by concurrent administration of II but in a few cases its protective action was partially or totally inhibited, depending on the resp. dose levels of both compds. .
- Thermoregulatory effects of peripheral catecholamines on the pigeon after treatment with thyroxine or thiouracil
- Thermoregulatory effects of peripheral catecholamines on the pigeon after treatment with thyroxine or thiouracil. Saarela, S.; Hissa, R. (Dep.In this study, 141-90-2 and 51-40-1 are also used. Zool., Univ. Oulu, Oulu, Finland). Comp. Biochem. Physiol. C, 56(1C), 25-30 (English) 1977. CODEN: CBPCBB. DOCUMENT TYPE: Journal CA Section: 2 (Hormone Pharmacology) Section cross-reference(s): 12 After treatment with thyroxine (I) [55-03-8] (75 .mu.g/kg), thiouracil (II) [141-90-2] (3 mg/kg), or 0.85% NaCl every 2 days for 3 weeks either at 22 or 2.degree., pigeons were peripherally injected with noradrenaline (III) [51-40-1] (1-3 mg/kg) at both 6 and 32.degree.; after I treatment, III caused more marked hypo- or hyperthermia at 6 or 32.degree. resp. than after treatment with II. Repeated I or II injections increased the plasma glucose level at 22.degree. but not at 2.degree.; there were no changes in lipolytic activity after 3 weeks of treatment. All examd. tissues of I-treated pigeons consumed more O in vitro than did those of II-treated pigeons and the I-treated tissues were more sensitive to added III (10-4M). Thus I potentiates the hypo- or hyperthermic effects of III below or above the thermoneutral zone and this effect is counteracted by II. .
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

